Ulonivirine (MK-8507; MK8507) is a novel potent and orally bioactive NNRTI/non-nucleoside reverse transcriptase inhibitor with antiviral activity. Ulonivirine is currently being developed in clinical trials for the treatment of HIV-1 infection. MK-8507 has high antiviral potency in vitro and pharmacokinetic (PK) properties that support once-weekly dosing.

纯度：≥98%

CAS：1591823-76-5